SCHEMBL5387159

SCHEMBL5387159

O=C(O)Cc1ccc2[nH]cc(CS)c2c1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 3/20 0.49
MAPT P10636 3/20 0.49
GAA P10253 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
POLB P06746 1/20 0.49
THRB P10828 1/20 0.49
DNMT1 P26358 1/20 0.49
RECQL P46063 1/20 0.49
CASP6 P55212 1/20 0.49
MCL1 Q07820 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
HPGD P15428 3/20 0.46
TSHR P16473 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
LMNA P02545 2/20 0.46
GLA P06280 1/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9755961 0.84 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTGAAMEN1
SCHEMBL28027132 0.81 KDM4E (0.47) ALDH1A1KDM4EMAPTGAAMEN1
SCHEMBL4609508 0.79 ALDH1A1 (0.55) ALDH1A1KDM4EMAPTGAAMEN1
SCHEMBL5387155 0.78 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTGAAMEN1
SCHEMBL28787476 0.78 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTGAAMEN1
SCHEMBL154385 0.71 ALDH1A1 (0.69) ALDH1A1KDM4EMAPTGAAMEN1
SCHEMBL29580629 0.71 ALDH1A1 (0.69) ALDH1A1KDM4EMAPTGAAMEN1
SCHEMBL27533852 0.71 ALDH1A1 (0.52) ALDH1A1KDM4EMAPTGAAMEN1
SCHEMBL5378636 0.71 LMNA (0.49) ALDH1A1KDM4EMAPTGAAMEN1
SCHEMBL31173808 0.69 GPR17 (0.47) ALDH1A1KDM4EMAPTGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189739-B2 Compounds and methods to treat cardiac failure and other disorders SCIOS, INC. (US) 2007-03-13 US disclosed
EP-1080078-B1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC (US) 2006-02-01 EP disclosed
US-6589954-B1 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful SCIOS, INC. 2003-07-08 US disclosed
US-6340685-B1 ANTIINFLAMMATORY AGENTS SCIOS, INC. 2002-01-22 US disclosed
EP-1080078-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 2001-03-07 EP disclosed
WO-1999061426-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 1999-12-02 WO disclosed